Silk Road Medical, Inc. (SILK): Market Cap to Revenue

Symbol and logo of brand Silk Road Medical, Inc. (SILK)

Silk Road Medical, Inc. (SILK) relies on exclusive TCAR technology, which eliminates the risk of embolism during surgeries. This price-to-sales chart confirms asset stability, where the current status is 5.80. Niche leadership in vascular surgery minimizes risks, while the scaling strategy prepares the company for integration into a global medtech behemoth.

SILK Silk Road Medical, Inc. P/S Multiple (07/04/2022 - 09/28/2024)

Analytical breakdowns for silkroadmed.com (SILK)

- share price and consensus valuation forecast:
General company analysis:SILK Silk Road Medical, Inc.
Core merchandise of Silk Road Medical, Inc

For Silk Road Medical, Inc. (SILK) and its unique TCAR technology, the price-to-sales ratio determines how much investors are willing to pay for every dollar of sales from its innovative artery cleansing systems. By analyzing the historical P/S, one can separate market noise from the business's fundamental value, assessing whether the defensive qualities of the company's patents are overvalued relative to actual cash flows.

Competitors of Silk Road Medical, Inc

DXCM (DexCom Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple PEN (penumbrainc.com)|NOVT - Market Cap to Revenue|Haemonetics - P/S Multiple|Price to Sales Inspire Medical Systems|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Medical) - P/S Multiple|InMode Corp (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics, Inc. SRDX|P/S Multiple SENS (senseonics.com)|P/S Multiple NeuroPace Inc NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|Outset Medical Corp (OM) - Price-to-Revenue Ratio|SmartVest - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR Inc) - P/S Multiple|Price to Sales AVITA Medical Inc. RCEL|Price-to-Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Price-to-Revenue Multiple|EDAP TMS SA - Market Cap to Revenue|P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx LUNG|TELA Bio (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corp.)|Price-to-Revenue Ratio sensushealthcare.com|Market Cap to Revenue Zynex, Inc. (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio inspira-technologies.com IINN|Market Cap to Sales Volume ICU (SeaStar Medical Holding Corp.)|IRIX: Market Cap to Revenue|ibs.inc - Market Cap to Sales Volume|XAIR: P/S Multiple|Price-to-Sales Ratio PFSA (Profusa Inc.)|Market Cap to Revenue SSKN|Price-to-Revenue Ratio GCTK|Price-to-Revenue Ratio NanoVibronix (NAOV)|Venus Concept - Market Cap to Revenue Ratio|P/S Multiple NUWE (Nuwellis Corp)|Market Capitalization-to-Revenue Ratio AEMD|ASXC - Price-to-Revenue Ratio|Price-to-Revenue Multiple Avinger, Inc (AVGR)|BSGM: P/S Multiple|Cutera (CUTR) - P/S Multiple|KNW (Know Labs) - P/S Multiple|Market Cap to Revenue Inari Medical (NARI)|Price-to-Revenue Ratio nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Market Capitalization-to-Revenue Ratio